Many people reported positive effects, such as reduced anxiety and depression symptoms, increased energy, clearer thinking, and better control over compulsive behaviors like smoking and shopping
Discontinuation due to side effects ran at 7% in Phase 2 data, which is lower than Semaglutides 11% discontinuation rate despite Semaglutide having a higher reported nausea incidence at 44%
If approved in the UK, orforglipron (Foundayo) may be prescribed to adults: With a BMI of 30 or above With a BMI of 27 or above and a related health condition (such as high blood pressure or type 2 diabetes) What orforglipron (Foundayo) dosages and strengths are available
Following this strategy, different metabolic pathways for carbohydrate, lipid, and protein metabolism could be influenced simultaneously
It is vital to consult a doctor before stopping Semaglutide